Status:
UNKNOWN
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Cancer of Esophagus
Cancer, Lung
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective or the trial is to study the influence of a combined therapy involving protein-rich individualized nutritional therapy and highly effective muscle training via personalized whole-body el...
Detailed Description
Tumor specific and inflammation promoting mediators lead to a loss of appetite, to systemic inflammation processes and to metabolic and hormonal changes including anabolic resistance. Consequences her...
Eligibility Criteria
Inclusion
- Patients with esophageal and/or bronchial carcinoma in curative or palliative treatment
Exclusion
- Healthy persons or patients under age
- Pregnancy, Lactation
- Psychological disorders, epilepsia, sever neurological disorders
- Participation in other exercise- or nutrition studies within the last 6 months
- Acute cardiovascular disease
- Rheuma
- Intake of anabolic drugs,
- Skin injuries in the area of electrode placements
- Electronic implants (defibrillator, pacemaker)
- Persons in mental hospitals by order of authorities or jurisdiction
Key Trial Info
Start Date :
March 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03274349
Start Date
March 17 2017
End Date
March 1 2021
Last Update
October 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Erlangen, Department of Medicine 1
Erlangen, Bavaria, Germany, 91054